Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.

导出 OA

翻译打印收藏纠错

作者： Linda T,Vahdat ^[1] ; Agustin A,Garcia ; Charles,Vogel ; Christine,Pellegrino ; Deborah L,Lindquist ; Nicholas,Iannotti ; Prashanth,Gopalakrishna ; Joseph A,Sparano

作者单位： Weill Cornell Medical College, 425 East 61st Street, 8th Floor, New York, NY 10065, USA. ltv2001@med.cornell.edu ^[1]

主题词成年人(Adult);乳腺肿瘤(Breast Neoplasms);埃博霉素类(Epothilones);女(雌)性(Female);呋喃类(Furans);人类(Humans);酮类(Ketones);中年人(Middle Aged);肿瘤转移(Neoplasm Metastasis);周围神经系统疾病(Peripheral Nervous System Diseases);存活率(Survival Rate)

DOI 10.1007/s10549-013-2574-2

PMID 23877339

发布时间 2022-03-11

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览44

Breast cancer research and treatment

2013年140卷2期

341-51页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.

Breast cancer research and treatment

相似文献

Breast cancer research and treatment

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Eribulin mesylate versus ixabepilone in patients with metastatic breast cancer: a randomized Phase II study comparing the incidence of peripheral neuropathy.

Breast cancer research and treatment

相似文献

Breast cancer research and treatment

相关期刊

检索历史清除